Vitamins and Imfinzi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamins (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Imfinzi (durvalumab). Common drug interactions include malignant neoplasm progression among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Vitamins and Imfinzi. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamins?

Vitamins has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 122,456 Vitamins users. Check the latest studies of Vitamins.

What is Imfinzi?

Imfinzi has active ingredients of durvalumab. eHealthMe is studying from 8,353 Imfinzi users. Check the latest studies of Imfinzi.

On Jul, 16, 2026

17 people who take Vitamins and Imfinzi together, and have interactions are studied.

What are the common drug interactions of Vitamins and Imfinzi, by gender? *:

female:

Malignant neoplasm progression (cancer tumour came back)
Death
Asthenia (weakness)
Haemoglobin decreased
Malaise (a feeling of general discomfort or uneasiness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

male:

Death
Abdominal pain upper
Adrenal disorder
Cholecystitis (infection of gallbladder)
Constipation
Euthyroid sick syndrome (low serum levels of thyroid hormones in clinically euthyroid patients with nonthyroidal systemic illness)
Hypophysitis (inflammation of the pituitary gland)
Intestinal perforation (complete penetration of the wall of the intestine)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Thyroiditis (inflammation of thyroid gland)

What are the common drug interactions of Vitamins and Imfinzi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Enteritis (inflammation of the small intestine)
Hyperthyroidism (over activity of the thyroid gland)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Rash
Adrenal disorder
Hypophysitis (inflammation of the pituitary gland)
Thyroiditis (inflammation of thyroid gland)
Abdominal pain upper

60+:

Death
Malignant neoplasm progression (cancer tumour came back)
Encephalitis (inflammation of the brain)
Cholecystitis (infection of gallbladder)
Constipation
Euthyroid sick syndrome (low serum levels of thyroid hormones in clinically euthyroid patients with nonthyroidal systemic illness)
Intestinal perforation (complete penetration of the wall of the intestine)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the existing conditions these people have? *

Biliary Cancer Metastatic: 7 people, 41.18%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 29.41%
Insomnia (sleeplessness): 2 people, 11.76%
Depression: 2 people, 11.76%
Biliary Neoplasm (biliary tumour): 2 people, 11.76%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 5.88%
Pneumonia: 1 person, 5.88%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.88%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 1 person, 5.88%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamins and Imfinzi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously